Aminocaproic acid use in specific populations: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Aminocaproic acid}} {{CMG}}; {{AE}} {{SS}} ==Use In Specific Populations== ===Pregnancy=== Pregnancy Category C. Animal reproduction studies have not been conduct...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Aminocaproic acid#Use in Specific Populations]]
{{Aminocaproic acid}}
{{CMG}}; {{AE}} {{SS}}
 
==Use In Specific Populations==
===Pregnancy===
Pregnancy Category C. Animal reproduction studies have not been conducted with AMICAR. It is also not known whether AMICAR can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. AMICAR should be given to a pregnant woman only if clearly needed.
 
===Nursing Mothers===
 
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when AMICAR is administered to a nursing woman.
 
===Pediatric Use===
 
Safety and effectiveness in pediatric patients have not been established.<ref>{{Cite web  | last =  | first =  | title = DailyMed: Search | url = http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=Aminocaproic+acid&x=-1148&y=-229 | publisher =  | date =  | accessdate = 31 January 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Antifibrinolytics]]
[[Category:Cardiovascular Drugs]]
[[Category:Amino acids]]
[[Category:Antifibrinolytics]]
[[Category:Hematology]]
 
[[ja:Ε-アミノカプロン酸]]
[[pl:Kwas ε-aminokapronowy]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 15:38, 21 July 2014